Cargando…
Engineering a dual vaccine against COVID-19 and tuberculosis
The COVID-19 pandemic, caused by SARS-CoV-2 virus, has been one of the top public health threats across the world over the past three years. Mycobacterium bovis BCG is currently the only licensed vaccine for tuberculosis, one of the deadliest infectious diseases in the world, that is caused by Mycob...
Autores principales: | Guthrie, Carlyn Monèt, Tan, Xuejuan, Meeker, Amber Cherry, Self, Ashton Elisabeth, Liu, Lin, Cheng, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641007/ https://www.ncbi.nlm.nih.gov/pubmed/37965265 http://dx.doi.org/10.3389/fcimb.2023.1273019 |
Ejemplares similares
-
Engineering zinc oxide hybrid selenium nanoparticles for synergetic anti-tuberculosis treatment by combining Mycobacterium tuberculosis killings and host cell immunological inhibition
por: Lin, Wensen, et al.
Publicado: (2023) -
Subunit Vaccine ESAT-6:c-di-AMP Delivered by Intranasal Route Elicits Immune Responses and Protects Against Mycobacterium tuberculosis Infection
por: Ning, Huanhuan, et al.
Publicado: (2021) -
The gut microbiome: A line of defense against tuberculosis development
por: Yu, Ziqi, et al.
Publicado: (2023) -
The Deconstructed Granuloma: A Complex High-Throughput Drug Screening Platform for the Discovery of Host-Directed Therapeutics Against Tuberculosis
por: Huang, Lu, et al.
Publicado: (2018) -
How the corona pandemic affects the global fight against tuberculosis and how to react
por: Ulrichs, Timo
Publicado: (2023)